Toggle navigation
×
Products
Clinical Products
Clinical Drug Data
Drug list data, APIs, and tools for your products
Clinical Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Scientific Products
Scientific Drug Data
Molecular level drug data, APIs and tools
Use Cases
Drug Discovery
Discover novel drug candidates
Drug Repurposing
Identify new repurposing opportunities
Precision Medicine
Clinical decision support for your applications
Machine Learning
Structured and curated data for your AI applications
Telehealth
Power your remote care software
Learn More
White Papers
Read about how real customers use DrugBank
Webinars
Access our free online video tutorials
Publications Directory
Search publications citing DrugBank in their research
Help Center
General Information
Data Formats
API Support
Articles
Tutorials
About
About
Blog
Company
Careers
Contact
Contact
General
Sales
Support
Sign In
Sign In
API Portal
Commercial Downloads Portal
Help Center
|
Learn more about our products and services
NAV
General
Data Formats
API Support
Articles
Tutorials
Glossary
A
Active ingredient
Adverse effect
Agonist
Allergenics
Ames test
Antagonist
Approved drug
Associated condition
ATC codes
B
Binding Strength
Biodegradation
Biotech drug
Black box warning
Blood brain barrier
Boiling point
C
Caco-2 permeable
Carcinogenicity
Carrier
CAS Number
Cell transplant therapies
Chemical Formula
Clinical trial
Condition
Contraindication
CYP450 1A2 substrate ADMET Feature Prediction
CYP450 2C19 inhibitor ADMET Feature Prediction
CYP450 2C9 inhibitor ADMET Feature Prediction
CYP450 2C9 substrate ADMET Feature Prediction
CYP450 2D6 inhibitor ADMET Feature Prediction
CYP450 2D6 substrate ADMET Feature Prediction
CYP450 3A4 inhibitor ADMET Feature Prediction
CYP450 3A4 substrate ADMET Feature Prediction
CYP450 inhibitory promiscuity
Cytochrome P-450 Interactions
D
Dosage form
Dosage route
Drug
Drug active moiety
Drug Binding
Drug Card
Drug Group
Drug Identification Number (DIN)
Drug Indication
Drug interaction
Drug label
Drug patent
Drug Product
E
Enzyme
Ester prodrug
Evidence level
Evidence type
Experimental drug
Experimental property
F
Food interaction
Formulation Strength
G
Gene therapies
H
hERG inhibition (predictor I)
hERG inhibition (predictor II)
Human Intestinal Absorption
Hydrophobicity
I
ICD10
Illicit drug
Inactive ingredient
InChI
InChI key
Inducer
Inhibitor
Investigational drug
Isoelectric point
IUPAC Name
J
K
L
Lipinski's rule of five
Log S
LogP
M
Management
Mechanism of Action
MedDRA
Melting point
Metabolic Reaction
Metabolite
Molecular Weight
N
Narrow Therapeutic Index Drug
National Drug Code (NDC)
Nucleic acid based therapies
Nutraceutical drug
O
Off label
P
P-glycoprotein inhibitor I ADMET Feature Prediction
P-glycoprotein inhibitor II ADMET Feature Prediction
P-glycoprotein substrate ADMET Feature Prediction
Pharmacological Action
pKa
Polypeptide
Predicted ADMET features
Predicted Bioavailability
Predicted property
Product Concept
Protein based therapies
Q
R
Radioactivity
Rat acute toxicity ADMET Feature Prediction
Reaction Type
Renal organic cation transporter ADMET Feature Prediction
S
Salt
Severity
Small Molecule Drug
SMILES
SNP
Substrate
T
Target
Transporter
U
V
Vaccines
Vet approved drug
W
Water solubility
Withdrawn drug
X
Y
Z
Field Descriptions
FAQ's
Release Notes
CSV Format
JSON Format
XML Format
Clinical Data Support
Scientific Data Support
API Authentication
API Portal Help
Indications
Pharmacogenomics
Product Concepts
Product Packages
SQL Examples
DrugBank Online
Product Concepts
Drug-Drug Interactions
Indications
Glossary
A
Active ingredient
Adverse effect
Agonist
Allergenics
Ames test
Antagonist
Approved drug
Associated condition
ATC codes
B
Binding Strength
Biodegradation
Biotech drug
Black box warning
Blood brain barrier
Boiling point
C
Caco-2 permeable
Carcinogenicity
Carrier
CAS Number
Cell transplant therapies
Chemical Formula
Clinical trial
Condition
Contraindication
CYP450 1A2 substrate ADMET Feature Prediction
CYP450 2C19 inhibitor ADMET Feature Prediction
CYP450 2C9 inhibitor ADMET Feature Prediction
CYP450 2C9 substrate ADMET Feature Prediction
CYP450 2D6 inhibitor ADMET Feature Prediction
CYP450 2D6 substrate ADMET Feature Prediction
CYP450 3A4 inhibitor ADMET Feature Prediction
CYP450 3A4 substrate ADMET Feature Prediction
CYP450 inhibitory promiscuity
Cytochrome P-450 Interactions
D
Dosage form
Dosage route
Drug
Drug active moiety
Drug Binding
Drug Card
Drug Group
Drug Identification Number (DIN)
Drug Indication
Drug interaction
Drug label
Drug patent
Drug Product
E
Enzyme
Ester prodrug
Evidence level
Evidence type
Experimental drug
Experimental property
F
Food interaction
Formulation Strength
G
Gene therapies
H
hERG inhibition (predictor I)
hERG inhibition (predictor II)
Human Intestinal Absorption
Hydrophobicity
I
ICD10
Illicit drug
Inactive ingredient
InChI
InChI key
Inducer
Inhibitor
Investigational drug
Isoelectric point
IUPAC Name
J
K
L
Lipinski's rule of five
Log S
LogP
M
Management
Mechanism of Action
MedDRA
Melting point
Metabolic Reaction
Metabolite
Molecular Weight
N
Narrow Therapeutic Index Drug
National Drug Code (NDC)
Nucleic acid based therapies
Nutraceutical drug
O
Off label
P
P-glycoprotein inhibitor I ADMET Feature Prediction
P-glycoprotein inhibitor II ADMET Feature Prediction
P-glycoprotein substrate ADMET Feature Prediction
Pharmacological Action
pKa
Polypeptide
Predicted ADMET features
Predicted Bioavailability
Predicted property
Product Concept
Protein based therapies
Q
R
Radioactivity
Rat acute toxicity ADMET Feature Prediction
Reaction Type
Renal organic cation transporter ADMET Feature Prediction
S
Salt
Severity
Small Molecule Drug
SMILES
SNP
Substrate
T
Target
Transporter
U
V
Vaccines
Vet approved drug
W
Water solubility
Withdrawn drug
X
Y
Z
